Pelago Bioscience AB
Johan Karlsson has held various key roles in finance and business support throughout their career. Johan has successfully managed finance functions, led post-merger integration projects, and established training programs within finance organizations. Johan has also demonstrated strong project management skills, such as planning and executing large-scale events. With a Master of Science degree in Finance and Accounting and a Bachelor's degree in Business and Economics, Johan has a solid educational background to support their professional experience.
This person is not in any teams
Pelago Bioscience AB
Pelago Bioscience AB is founded to accelerate the use and value of the CETSA® technology in Drug Discovery and diagnostics. We know that the need for Target Engagement studies is large and increasing and there is no single technology with the same opportunities to fill this need as CETSA®. We will: - Make more relevant data available to our customers at an earlier stage of the Drug Discovery process - Enable filtering of compounds based on physiologically relevant data to facilitate better decisions in Drug Discovery programs - Provide our customers with CETSA® based Target Engagement data in vitro and in vivo - Improve translation from laboratory to patient by using a single technology - CETSA® - Facilitate development of novel medicine in clinical trials using CETSA® - Develop diagnostic kits, companion diagnostics and tools for monitoring Target Engagement during patient treatment using CETSA® Pelago Bioscience AB will by these accomplishments add value to Drug Discovery programs allowing for faster and better development of new and improved drugs. By developing the CETSA® technology for general clinical use as a diagnostic and treatment monitoring tool we aspire to improve the lives and health of patients.